Clinical Trials Sponsored by Warner Chilcott

Total 2154 results

Dana-Farber Cancer Institute

Completed

Step Into Support for Endurance and Strength (SISTERS) (SISTERS)

Gynecologic Cancer

United States
Dana-Farber Cancer Institute

Completed

Image-Guided Gynecologic Brachytherapy (AMIGO)

Cervical Cancer | Vaginal Cancer | Uterine Cancer | Carcinoma of the Vulva

United States
Dana-Farber Cancer Institute

Completed

Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy

Early Stage Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II

United States
Dana-Farber Cancer Institute

Completed

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Breast Cancer | Prostate Cancer | Patient Engagement | Patient Satisfaction | Patient Preference

United States
Dana-Farber Cancer Institute

Completed

Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer (MAYA)

Stress | Anxiety | Oncology

United States
Dana-Farber Cancer Institute

Completed

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

Other Cancer

United States
Dana-Farber Cancer Institute

Completed

Videos for Advance Care Planning in Young Adults

Advanced Cancer

United States
Dana-Farber Cancer Institute

Completed

Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

Cancer

United States
Dana-Farber Cancer Institute

Completed

Intravenous Magnesium in Patients Receiving Cisplatin

Mesothelioma

United States
Banner Life Sciences LLC

Completed

Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects

Relapsing Remitting Multiple Sclerosis

United States
Dana-Farber Cancer Institute

Completed

Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy

Prostate Cancer

United States
Dana-Farber Cancer Institute

Completed

Cisplatin + RT for Triple Negative Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Glioblastoma

United States
Dana-Farber Cancer Institute

Terminated

The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Gynecologic Tumor

United States
Dana-Farber Cancer Institute

Completed

The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients

Gastro Intestinal Cancer

United States
Dana-Farber Cancer Institute

Completed

Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD

Chronic Versus Graft Host Disease

United States
Dana-Farber Cancer Institute

Completed

Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Dana-Farber Cancer Institute

Completed

Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning

Prostate Cancer | Adenocarcinoma of the Prostate Stage I | Adenocarcinoma of the Prostate Stage II | Adenocarcinoma of the Prostate Stage III

United States
Dana-Farber Cancer Institute

Completed

BKM120 For Triple Negative Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Exercise and Metformin in Colorectal and Breast Cancer Survivors

Breast Cancer | Colorectal Cancer

United States
Dana-Farber Cancer Institute

Completed

Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Lelo Inc.
Banner Health

Completed

Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)

Sexual Dysfunction | Stress Urinary Incontinence

United States
Dana-Farber Cancer Institute

Completed

Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant

Graft Versus Host Disease

United States
Dana-Farber Cancer Institute

Completed

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Lymphoma | Leukemia | Myelodysplastic Syndrome

United States
Dana-Farber Cancer Institute

Terminated

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Multiple Myeloma | Thrombocytopenia

United States
Justin Parker Neurological Institute

Terminated

The Effectiveness of Anti-Gravity Treadmill Training

Lumbar Degenerative Disc Disease

United States
Dana-Farber Cancer Institute

Completed

Cabozantinib for Metastatic Triple Negative BrCa

Breast Cancer

United States
Dana-Farber Cancer Institute

Terminated

Simvastatin in Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Dana-Farber Cancer Institute

Terminated

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Non-Small Cell Lung Cancer, Head and Neck Cancer

United States
Dana-Farber Cancer Institute

Withdrawn

Tivozanib + Gemcitabine in Metastatic RCC

Renal Cell Carcinoma

United States
Dana-Farber Cancer Institute

Completed

Observational Study of Iron Overload in Stem Cell Transplantation

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome

United States
Rayner Intraocular Lenses Limited

Terminated

A Multi Focal Visual Outcome Study Using Different Near Additions

Cataract | Aphakia

Germany, Lithuania
Banner Health
Forest Laboratories

Terminated

Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population

Fibromyalgia

United States
Dana-Farber Cancer Institute

Completed

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Neoplasms

United States
Dana-Farber Cancer Institute

Completed

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Dana-Farber Cancer Institute

Completed

MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients

Prostate Cancer

United States
Dana-Farber Cancer Institute

Not yet recruiting

PediCARE Health Equity Intervention in High-Risk Neuroblastoma

Neuroblastoma | Pediatric Cancer | High-risk Neuroblastoma | Financial Stress | Disparities | Poverty

United States
Dana-Farber Cancer Institute

Recruiting

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Leukemia, Myeloid | Myeloproliferative Disorders | Myeloproliferative Neoplasm

United States
Dana-Farber Cancer Institute

Recruiting

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreatic Neoplasm | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma

United States
Dana-Farber Cancer Institute

Recruiting

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Multiple Myeloma | Stem Cell Transplant Complications

United States
Dana-Farber Cancer Institute

Recruiting

Investigating Hereditary Risk In Thoracic Cancers (INHERIT) (INHERIT)

Lung Cancer | Genetic Disease | Genetic Predisposition | Hereditary Diseases

United States
Dana-Farber Cancer Institute

Not yet recruiting

UNTIRE: Cancer-related Fatigue With Digital Treatment

Fatigue | Colorectal Cancer

United States
Dana-Farber Cancer Institute

Recruiting

Home Transfusion for HEME

Hematologic Malignancy

United States
Dana-Farber Cancer Institute

Recruiting

Acalabrutinib in CNSL

Refractory Central Nervous System Lymphoma | Central Nervous System Lymphoma | Recurrent Central Nervous System Lymphoma

United States
Dana-Farber Cancer Institute

Recruiting

Safe Accelerated Venetoclax Escalation in CLL (SAVE)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Dana-Farber Cancer Institute

Recruiting

Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

Obesity | Endometrial Carcinoma | Endometrial Cancer Stage I | Endometrial Intraepithelial Neoplasia | EIN

United States
Dana-Farber Cancer Institute

Recruiting

Geriatric Thoracic Surgery Ambulation Challenge

Surgery | Thoracic Diseases | Therapy, Exercise

United States
Dana-Farber Cancer Institute

Recruiting

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Head and Neck Cancer

United States
Dana-Farber Cancer Institute

Recruiting

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Lymphoproliferative Disorders | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Leukemia, Lymphocytic, Chronic

United States
Dana-Farber Cancer Institute

Active, not recruiting

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Breast Cancer

United States

Clinical Trials Sponsored by Warner Chilcott

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations